Weed (BUDZ) Operating Leases (2022 - 2026)
Weed (BUDZ) posted quarterly Operating Leases of $1519.0 for Q1 2026, down 89.98% year-over-year from $15155.0 in Q1 2025, and down 68.03% quarter-over-quarter from $4751.0 in Q4 2025.
Weed (BUDZ) Operating Leases (2022 - 2026) Analysis & Trends
Weed's Operating Leases history runs 5 years deep, the most recent figure standing at $1519.0 for Q1 2026.
- In Q1 2026, Operating Leases fell 89.98% year-over-year to $1519.0; the TTM figure through Mar 2026 stood at $1519.0 (down 89.98% YoY), while the FY2025 annual figure was $4751.0, down 74.37% from the prior year.
- Operating Leases for Q1 2026 stood at $1519.0, down from $4751.0 in the prior quarter.
- The five-year high for Operating Leases was $50139.0 in Q2 2022, with the low at $1519.0 in Q1 2026.
- The 5-year median for Operating Leases is $26806.0 (2024), against an average of $26399.3.
- The sharpest annual moves came in 2023 and 2026: Operating Leases fell 24.27% in 2023, then tumbled 89.98% in 2026.
- Weed's Operating Leases stood at $44130.0 in 2022, then slipped by 28.27% to $31653.0 in 2023, then plunged by 41.43% to $18538.0 in 2024, then tumbled by 74.37% to $4751.0 in 2025, then tumbled by 68.03% to $1519.0 in 2026.
- Business Quant data shows BUDZ's Operating Leases at $1519.0 in Q1 2026, $4751.0 in Q4 2025, and $8262.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Weed | 3.13 Mn | 3.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,519.00 |
| Dec 31, 2025 | 4,751.00 |
| Sep 30, 2025 | 8,262.00 |
| Jun 30, 2025 | 11,730.00 |
| Mar 31, 2025 | 15,155.00 |
| Dec 31, 2024 | 18,538.00 |
| Sep 30, 2024 | 21,878.00 |
| Jun 30, 2024 | 25,177.00 |
| Mar 31, 2024 | 28,435.00 |
| Dec 31, 2023 | 31,653.00 |
| Sep 30, 2023 | 34,831.00 |
| Jun 30, 2023 | 37,969.00 |
| Mar 31, 2023 | 41,069.00 |
| Dec 31, 2022 | 44,130.00 |
| Sep 30, 2022 | 47,153.00 |
| Jun 30, 2022 | 50,139.00 |